Full Content is available to subscribers

Subscribe/Learn More  >

Drug Eluting Stents: A New Class of Combination Product

[+] Author Affiliations
Debashis Dutta

Biosensors International, Singapore

Paper No. BioMed2007-38044, pp. 47-48; 2 pages
  • ASME 2007 2nd Frontiers in Biomedical Devices Conference
  • ASME 2007 2nd Frontiers in Biomedical Devices
  • Irvine, California, USA, June 7–8, 2007
  • Conference Sponsors: Nanotechnology Institute
  • ISBN: 0-7918-4266-5 | eISBN: 0-7918-3797-1
  • Copyright © 2007 by ASME


Drug Eluting Stent (DES) is a drug-device combination product. It is a metal stent coated with a pharmacological agent (drug). The drug interferes with the process of restenosis and prevents the reblocking of the artery. DES has been shown to reduce the incidence of restenosis from 20–30% range to single digits. A polymer is usually mixed -in with the drug to control the release of the drug into the vessel wall.

Copyright © 2007 by ASME
Topics: Drugs , stents



Interactive Graphics


Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging and repositioning the boxes below.

Related eBook Content
Topic Collections

Sorry! You do not have access to this content. For assistance or to subscribe, please contact us:

  • TELEPHONE: 1-800-843-2763 (Toll-free in the USA)
  • EMAIL: asmedigitalcollection@asme.org
Sign In